{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:03:08Z","timestamp":1761490988926,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Science and Technology project of Zhejiang Drug Administration in 2020","award":["2020001"],"award-info":[{"award-number":["2020001"]}]},{"name":"National Science and Technology Major Projects for Major New Drugs Innovation and Development","award":["2017ZX09101001"],"award-info":[{"award-number":["2017ZX09101001"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jpba.2020.113324","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T20:31:12Z","timestamp":1587587472000},"page":"113324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Characterization of 28 unknown impurities in 16-membered macrolides by liquid chromatography coupled with ion trap\/time-of-flight mass spectrometry"],"prefix":"10.1016","volume":"186","author":[{"given":"Guijun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2020.113324_bib0005","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijantimicag.2017.05.020","article-title":"16-membered macrolide antibiotics: a review","volume":"51","author":"Arsic","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jpba.2020.113324_bib0010","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/138527211794072588","article-title":"Modifications and biological activity of natural and semisynthetic 16-membered macrolide antibiotics","volume":"15","author":"Przybylski","year":"2011","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.jpba.2020.113324_bib0015","first-page":"2","article-title":"Immunomodulatory properties of macrolides: overview and historical perspective","volume":"117","author":"Rubin","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jpba.2020.113324_bib0020","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.1021\/jm300356u","article-title":"N-Substituted-2\u2032-O,3\u2032-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity","volume":"55","author":"Bosnar","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2020.113324_bib0025","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/bab.1443","article-title":"The effect of surfactant on fermentation of kitasamycin in Streptomyces kitasatoensis","volume":"63","author":"Zheng","year":"2016","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.jpba.2020.113324_bib0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.aca.2004.11.062","article-title":"Identification of the components of 16-membered macrolide antibiotics by LC\/MS","volume":"535","author":"Hu","year":"2005","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2020.113324_bib0035","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/rcm.8439","article-title":"Characterization of a new component and impurities in josamycin by trap\u2010free two\u2010dimensional liquid chromatography coupled to ion trap time\u2010of\u2010flight mass spectrometry","volume":"33","author":"Liu","year":"2019","journal-title":"Rapid Commun. Mass Spectrom."},{"year":"2020","series-title":"Q3A. Impurities","key":"10.1016\/j.jpba.2020.113324_bib0040"},{"year":"2015","series-title":"Chinese Pharmacopoeia Commission","key":"10.1016\/j.jpba.2020.113324_bib0045"},{"year":"2016","series-title":"European Pharmacopoeia, 9.0","key":"10.1016\/j.jpba.2020.113324_bib0050"},{"year":"2017","series-title":"British Pharmacopoeia","key":"10.1016\/j.jpba.2020.113324_bib0055"},{"year":"2016","series-title":"The Japanese Pharmacopoeia, Seventeenth Edition (JP17)","key":"10.1016\/j.jpba.2020.113324_bib0060"},{"key":"10.1016\/j.jpba.2020.113324_bib0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jpba.2017.06.069","article-title":"Identification of impurities in macrolides by liquid chromatography\u2013mass spectrometric detection and prediction of retention times of impurities by constructing quantitative structure\u2013retention relationship (QSRR)","volume":"145","author":"Zhang","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113324_bib0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpba.2012.01.012","article-title":"Characterization of impurities in josamycin using dual liquid chromatography combined with mass spectrometry","volume":"73","author":"Van den Bossche","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"year":"2012","series-title":"Commissioner of the Korea Food and Drug Administration","key":"10.1016\/j.jpba.2020.113324_bib0075"},{"key":"10.1016\/j.jpba.2020.113324_bib0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02491707","article-title":"RP-HPLC determination of midecamycin and related impurities","volume":"57","author":"Ying","year":"2003","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2020.113324_bib0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jpba.2013.05.043","article-title":"Characterization of the components of meleumycin by liquid chromatography with photo-diode array detection and electrospray ionization tandem mass spectrometry","volume":"84","author":"Wang","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113324_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113170","article-title":"Universal quantification method of degradation impurities in 16-membered macrolides using HPLC-CAD and study on source of the impurities","volume":"184","author":"Wang","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113324_bib0095","first-page":"52","article-title":"Determination of the related substance of josamycin by HPLC","volume":"22","author":"Wang","year":"2011","journal-title":"China Pharmacy"},{"key":"10.1016\/j.jpba.2020.113324_bib0100","first-page":"446","article-title":"Determination of the related substance of Josamycin by HPLC","volume":"29","author":"Wang","year":"2014","journal-title":"West Chin. Med. J."},{"key":"10.1016\/j.jpba.2020.113324_bib0105","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s10337-019-03754-5","article-title":"Separation and characterization of new components and impurities in leucomycin by multiple heart-cutting two-dimensional liquid chromatography combined with ion trap\/time-of-flight mass spectrometry","volume":"82","author":"Wang","year":"2019","journal-title":"Chromatographia"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520305677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520305677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:06:29Z","timestamp":1760000789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708520305677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":21,"alternative-id":["S0731708520305677"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113324","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of 28 unknown impurities in 16-membered macrolides by liquid chromatography coupled with ion trap\/time-of-flight mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113324"}}